FDA Drug Application (201616) for HYDROCHLOROTHIAZIDE; IRBESARTAN by CIPLA LIMITED

Back to FDA Applications sponsored by CIPLA LIMITED

Application Number201616
Product Number001
FormTABLET; ORAL
Dosage12.5MG; 150MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameHYDROCHLOROTHIAZIDE; IRBESARTAN
Active IngredientHYDROCHLOROTHIAZIDE; IRBESARTAN

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient IRBESARTAN7


Back to FDA Applications sponsored by CIPLA LIMITED